Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : ALNY crawled time : 20:20 save search
New Results from ATLAS Phase 3 Program with Fitusiran Presented at ASH Annual Meeting 2021
Published: 2021-12-12 (Crawled : 20:20) - alnylam.com
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: 3.01%
H: 0.28%
C: -2.39%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
ALNY | $146.07 0.19% 0.18% 540K
|
Health Technology
|
| O: 2.8%
H: 0.0%
C: 0.0%
results phase 3
New Analyses of OXLUMO® (lumasiran) ILLUMINATE-A Results at the National Kidney Foundation Virtual Spring Clinical Meetings
Published: 2021-04-10 (Crawled : 20:20) - alnylam.com
ALNY | $146.07 0.19% 0.18% 540K
|
Health Technology
| Email alert
Add to watchlist
results kidney
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.